1993
DOI: 10.1016/s0040-4039(00)61716-1
|View full text |Cite
|
Sign up to set email alerts
|

The synthesis of modified achiral internucleoside linkages: -NHCH2CH2- linked oligonucleosides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

1994
1994
2005
2005

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(3 citation statements)
references
References 17 publications
0
3
0
Order By: Relevance
“…Imidazole (Nacalai Tesque), N- (methyl)imidazole (Nacalai Tesque), N- (phenyl)imidazole (Aldrich), N- ( p -acetylphenyl)imidazole (Aldrich), 2-(phenyl)imidazole (Nacalai Tesque), 4-(methyl)imidazole (Kishida), 4-(phenyl)imidazole (Tokyo Kasei), benzimidazole (Nacalai Tesque), N- (methyl)benzimidazole (Wako), 2-(methyl)benzimidazole (Nacalai Tesque), 2-(phenyl)benzimidazole (Nacalai Tesque), trifluoromethanesulfonic acid (Central Glass), p- toluenesulfonic acid (Aldrich), trifluoroacetic acid (Kishida), hydroperchloric acid (Wako), tetrafluoroboric acid (Aldrich), hexafluorophosphoric acid (Aldrich), N 6 -(benzoyl)-5‘- O -( p,p ‘-dimethoxytrityl)-2‘-deoxyadenosine 3‘-(2-cyanoethyl N , N -diisopropylphosphoramidite) ( 5 ) (Glen Research), N 4 -(acetyl)-5‘- O -( p,p ‘-dimethoxytrityl)-2‘-deoxycytidine 3‘-(2-cyanoethyl N , N -diisopropylphosphoramidite) ( 6 ) (Glen Research), N 2 -(isobutyryl)-5‘- O -( p,p ‘-dimethoxytrityl)-2‘-deoxyguanosine 3‘-(2-cyanoethyl N , N -diisopropylphosphoramidite) ( 7 ) (Glen Research), and 5‘- O -( p,p ‘-dimethoxytrityl)thymidine 3‘-(2-cyanoethyl N , N -diisopropylphosphoramidite) ( 8 ) (Glen Research), Primer Support T ( 41 ) (Amersham Pharmacia Biotech), N 6 -(phenoxyacetyl)-5‘- O -( p,p ‘-dimethoxytrityl)-2‘-deoxyadenosine 3‘-(2-cyanoethyl N , N -diisopropylphosphoramidite) ( 42 ) (Amersham Pharmacia Biotech), N 2 -( p -isopropylphenoxyacetyl)-5‘- O -( p,p ‘-dimethoxytrityl)-2‘-deoxyguanosine 3‘-(2-cyanoethyl N , N -diisopropylphosphoramidite) ( 43 ) (Amersham Pharmacia Biotech), the uridine derivative anchored on CPG ( 45 ) (pore size, 500 Å, Milligen or Glen Research), a 2-butanone peroxide/dimethyl phthalate solution (Kishida), and Pd[P(C 6 H 5 ) 3 ] 4 (Aldrich) were commercially supplied. The following compounds and a solution are reported in the literature or prepared by reported methods: azolium salts imidazolium triflate,25f imidazolium perchlorate N -(methyl)imidazolium triflate, N -(phenyl)imidazolium perchlorate, and benzimidazolium triflate;25a protected 2‘-deoxyribonucleoside 3‘-phosphoramidites 1 , 45c, 2 , 45c, 3 , 45c, and 4 ;45c 3‘- O -protected 2‘-deoxyribonucleosides 9 ,45a 10 , and 11 ; dideoxyribnonucleoside phosphates 17 , 18 , and 19 ;25a protected ribonucleoside 3‘-phosphoramidites 20 , 21 ,40f and 22 ; 2‘,3‘- O -protected ribonucleosides 24 ,38c 25 ,38c and 26 ;38c 2‘- O -( tert -butyldimethylsilyl)-5‘- O -( p,p ‘-dimethoxytrityl)uridine; 3‘- O -( tert -butyldimethylsilyl)-5‘- O -( p,p ‘-dimethoxytrityl)-adenosine; a 1.0 M tert -butyl hydroperoxide/toluene solution; , (allyloxy)bis(diisopropylamino)phosphine;…”
Section: Methodsmentioning
confidence: 99%
“…Imidazole (Nacalai Tesque), N- (methyl)imidazole (Nacalai Tesque), N- (phenyl)imidazole (Aldrich), N- ( p -acetylphenyl)imidazole (Aldrich), 2-(phenyl)imidazole (Nacalai Tesque), 4-(methyl)imidazole (Kishida), 4-(phenyl)imidazole (Tokyo Kasei), benzimidazole (Nacalai Tesque), N- (methyl)benzimidazole (Wako), 2-(methyl)benzimidazole (Nacalai Tesque), 2-(phenyl)benzimidazole (Nacalai Tesque), trifluoromethanesulfonic acid (Central Glass), p- toluenesulfonic acid (Aldrich), trifluoroacetic acid (Kishida), hydroperchloric acid (Wako), tetrafluoroboric acid (Aldrich), hexafluorophosphoric acid (Aldrich), N 6 -(benzoyl)-5‘- O -( p,p ‘-dimethoxytrityl)-2‘-deoxyadenosine 3‘-(2-cyanoethyl N , N -diisopropylphosphoramidite) ( 5 ) (Glen Research), N 4 -(acetyl)-5‘- O -( p,p ‘-dimethoxytrityl)-2‘-deoxycytidine 3‘-(2-cyanoethyl N , N -diisopropylphosphoramidite) ( 6 ) (Glen Research), N 2 -(isobutyryl)-5‘- O -( p,p ‘-dimethoxytrityl)-2‘-deoxyguanosine 3‘-(2-cyanoethyl N , N -diisopropylphosphoramidite) ( 7 ) (Glen Research), and 5‘- O -( p,p ‘-dimethoxytrityl)thymidine 3‘-(2-cyanoethyl N , N -diisopropylphosphoramidite) ( 8 ) (Glen Research), Primer Support T ( 41 ) (Amersham Pharmacia Biotech), N 6 -(phenoxyacetyl)-5‘- O -( p,p ‘-dimethoxytrityl)-2‘-deoxyadenosine 3‘-(2-cyanoethyl N , N -diisopropylphosphoramidite) ( 42 ) (Amersham Pharmacia Biotech), N 2 -( p -isopropylphenoxyacetyl)-5‘- O -( p,p ‘-dimethoxytrityl)-2‘-deoxyguanosine 3‘-(2-cyanoethyl N , N -diisopropylphosphoramidite) ( 43 ) (Amersham Pharmacia Biotech), the uridine derivative anchored on CPG ( 45 ) (pore size, 500 Å, Milligen or Glen Research), a 2-butanone peroxide/dimethyl phthalate solution (Kishida), and Pd[P(C 6 H 5 ) 3 ] 4 (Aldrich) were commercially supplied. The following compounds and a solution are reported in the literature or prepared by reported methods: azolium salts imidazolium triflate,25f imidazolium perchlorate N -(methyl)imidazolium triflate, N -(phenyl)imidazolium perchlorate, and benzimidazolium triflate;25a protected 2‘-deoxyribonucleoside 3‘-phosphoramidites 1 , 45c, 2 , 45c, 3 , 45c, and 4 ;45c 3‘- O -protected 2‘-deoxyribonucleosides 9 ,45a 10 , and 11 ; dideoxyribnonucleoside phosphates 17 , 18 , and 19 ;25a protected ribonucleoside 3‘-phosphoramidites 20 , 21 ,40f and 22 ; 2‘,3‘- O -protected ribonucleosides 24 ,38c 25 ,38c and 26 ;38c 2‘- O -( tert -butyldimethylsilyl)-5‘- O -( p,p ‘-dimethoxytrityl)uridine; 3‘- O -( tert -butyldimethylsilyl)-5‘- O -( p,p ‘-dimethoxytrityl)-adenosine; a 1.0 M tert -butyl hydroperoxide/toluene solution; , (allyloxy)bis(diisopropylamino)phosphine;…”
Section: Methodsmentioning
confidence: 99%
“…3'-Amino-3'-deoxynucleosides are also the key intermediates in the synthesis of several backbone-modified oligonucleotides. For example, the phosphodiester in the natural oligonucleotides can be replaced by guanidine [6 ± 9], amide [10] [11], urea [12], carbamate [13], and aminoalkyl derivatives [14] [15]. Such antisense oligonucleotides may have great potential as therapeutic and diagnostic agents.…”
mentioning
confidence: 99%
“…Compound 14 was treated with a solution of 3.0n NaOH (aq.) MeOH 1 : 1 to yield 3'-(benzylamino)-3'-deoxyguanosine (15). The pure compound 15 (207 mg, 95% from 13) was obtained by the C18 reversed-phase chromatography eluted with a gradient from H 2 O to MeOH/H 2 O 1 : 1.…”
mentioning
confidence: 99%